The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Aquilo Capital, L.p. since 2020.
This trader's CIK number is 1491371.
At the time of last reporting, Aquilo Capital, L.p. was the 10% Owner of Spero Therapeutics, Inc.. (stock ticker symbol SPRO).
Also see all insider trading activities at Spero Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2022 | SPRO | 607,543 | $7,437,563 | 1,901,796 | $4,279,041 | 0 | $0 |
| 2021 | SPRO | 847,540 | $14,357,395 | 103,000 | $1,967,217 | 0 | $0 |
| 2020 | SPRO | 0 | $0 | 564,933 | $9,168,330 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2022-09-22 | SPRO | Sale | 1,901,796 | 2.25 | 4,279,041 |
| 2022-04-26 | SPRO | Buy | 39,727 | 5.24 | 207,970 |
| 2022-03-30 | SPRO | Buy | 50,000 | 8.79 | 439,400 |
| 2022-03-14 | SPRO | Buy | 23,708 | 7.63 | 180,797 |
| 2022-02-28 | SPRO | Buy | 44,833 | 9.53 | 427,213 |
| 2022-02-18 | SPRO | Buy | 14,828 | 9.24 | 137,040 |
| 2022-01-31 | SPRO | Buy | 125,000 | 11.59 | 1,448,250 |
| 2022-01-24 | SPRO | Buy | 1,599 | 10.89 | 17,417 |
| 2022-01-18 | SPRO | Buy | 48,488 | 12.41 | 601,978 |
| 2022-01-10 | SPRO | Buy | 8,867 | 12.93 | 114,605 |
| 2021-12-29 | SPRO | Buy | 75,493 | 14.64 | 1,105,293 |
| 2021-12-30 | SPRO | Buy | 50,000 | 15.77 | 788,600 |
| 2021-12-31 | SPRO | Buy | 125,000 | 15.75 | 1,969,000 |
| 2021-10-29 | SPRO | Buy | 150,000 | 17.54 | 2,630,250 |
| 2021-09-30 | SPRO | Buy | 134,543 | 18.65 | 2,509,226 |
| 2021-09-13 | SPRO | Buy | 44,210 | 18.56 | 820,670 |
| 2021-09-14 | SPRO | Buy | 2,156 | 18.49 | 39,873 |
| 2021-09-09 | SPRO | Buy | 24,749 | 18.50 | 457,782 |
| 2021-08-30 | SPRO | Buy | 44,042 | 17.87 | 786,854 |
| 2021-08-31 | SPRO | Buy | 48,645 | 18.93 | 920,655 |
| 2021-08-20 | SPRO | Buy | 221,190 | 14.86 | 3,286,883 |
| 2021-08-23 | SPRO | Buy | 137,835 | 16.33 | 2,251,396 |
| 2021-08-24 | SPRO | Buy | 40,170 | 16.28 | 653,806 |
| 2021-02-08 | SPRO | Sale | 3,000 | 21.74 | 65,214 |
| 2021-02-02 | SPRO | Sale | 22,841 | 18.99 | 433,773 |
| 2021-02-01 | SPRO | Sale | 13,661 | 19.24 | 262,864 |
| 2021-02-04 | SPRO | Sale | 34,144 | 18.99 | 648,257 |
| 2021-02-03 | SPRO | Sale | 29,354 | 18.98 | 557,109 |
| 2020-12-17 | SPRO | Sale | 250,000 | 18.81 | 4,703,250 |
| 2020-12-16 | SPRO | Sale | 14,933 | 18.62 | 278,037 |
| 2020-11-09 | SPRO | Sale | 125,900 | 13.77 | 1,734,020 |
| 2020-11-04 | SPRO | Sale | 72,500 | 14.26 | 1,033,777 |
| 2020-11-05 | SPRO | Sale | 96,600 | 13.98 | 1,350,371 |
| 2020-11-06 | SPRO | Sale | 5,000 | 13.78 | 68,875 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Aquilo Capital, L.p. (10% Owner of Spero Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.